logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 부산지방법원 동부지원 2018.01.09 2017고합42
특정범죄가중처벌등에관한법률위반(뇌물)등
Text

1. Defendant A shall be punished by imprisonment with prison labor for one year.

36,973,700 won shall be additionally collected from the defendant.

(b) the defendant;

Reasons

Punishment of the crime

[criminal history] Defendant A was sentenced to a suspended sentence of two years on August 5, 2016, on the part of the Sungnam branch of Suwon branch of Suwon branch of the Republic of Korea for the crime of acceptance of bribe, and the said judgment became final and conclusive on May 17, 2017.

[Status of the Defendants] From April 2, 2007 to September 4, 2012, Defendant A was a full-time examiner of the P Committee under the National Health Insurance Review Evaluation Institute of the National Health Insurance Corporation (a quasi-governmental institution affiliated with the Ministry of Health and Welfare, which is deemed a public official; the head professor of Qua University R graduate school from September 2012 to February 2013; the former member of the P Committee from January 1, 2013 to December 31, 2014; and the former member of the P Committee from July 10, 2013 to August 12, 2015; and the latter member of the P Committee was employed as a non-permanent member of the Committee from July 10, 2013 to December 10, 2013 to December 31, 2013.

Defendant

C is a doctor working for the U hospital located in Yongsan-gu Seoul Metropolitan Government.

[Criminal facts]

1. In the process of performing the duties of examining or evaluating whether a drug is eligible for medical care benefits and the maximum amount and revaluations, etc. while serving as a non-standing review member of the committee of the committee of ordinary level as above, Defendant A, in compliance with the statutes and regulations related to the review or evaluation duties, shall faithfully perform his duties in accordance with fair procedures to maintain fairness and objectivity in evaluation. Defendant A’s failure to participate in research services, etc. to register medicine insurance from manufacturers, etc. during his/her term of office and did not receive money, goods, such as money, real estate, gift, entertainment, etc. from a pharmaceutical company or any other person related to duties such as a pharmaceutical company. However, even if he/she did not receive money or valuables from a pharmaceutical company or any other person related to duties such as pharmaceutical company, Defendant A’s violation of the above duties, thereby denying the following entry in relation to the duties of the Defendant, such as new drugs applied by the pharmaceutical company, W (hereinafter each

arrow